Olivier Michielin

基本信息

浏览量：432

职业迁徙

个人简介

developing new molecularly defined therapeutic approaches based on original bioinformatics techniques developed in my laboratory, as well as precision oncology programs based on multi-omics strategies and data science at the national level. I am currently full Professor and Chair of the Department of Oncology and the Precision Oncology Service at the Geneva University Hospital, and the co-Director of the Swiss Cancer Center Léman (SCCL) at Agora in Lausanne.

研究兴趣

论文共 449 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Acceptability of an Electronic Patient-Reported Outcomes-Based Model of Care to Monitor Symptoms Related to Cancer Treatment with Immune Checkpoint Inhibitors: Results from the IePRO Randomized Controlled Trial

André Manuel da Silva Lopes, Stellio Giacomini, Ambily Ulahannan, Celia Darnac,Sebastien Bugeia, Garance Gutknecht,Sara Colomer-Lahiguera, Gilliosa Spurrier-Bernard, Sofiya Latifyan,Alfredo Addeo,Olivier Michielin,Manuela Eicher

Seminars in oncology nursingpp.151903-151903, (2025)

引用0浏览0WOS引用

Treatment Sequence with Tebentafusp and Immune Checkpoint Inhibitors in Patients with Metastatic Uveal Melanoma and Metastatic GNA11/GNAQ Mutant Melanocytic Tumors

EUROPEAN JOURNAL OF CANCER (2025)

引用0浏览0WOS引用

Engineered CD4 TCR T Cells with Conserved High-Affinity TCRs Targeting NY-ESO-1 for Advanced Cellular Therapies in Cancer

Margaux Saillard, Mara Cenerenti,Patrick Reichenbach,Philippe Guillaume, Ziyang Su, Morteza Hafezi,Julien Schmidt, Julien Cesbron,Raphaël Genolet,Lise Queiroz,Julien Racle, Jean Villard,Raffaele Renella,Olivier Michielin,Vincent Zoete, Jean-Paul Rivals,Melita Irving, Daniel E Speiser,Alexandre Harari,David Gfeller,Olivier Adotevi,Francesco Ceppi,George Coukos,Pedro Romero,Camilla Jandus

Science advancesno. 26 (2025): eadu5754-eadu5754

引用0浏览0WOS引用

Clinical Outcomes and Management Following Progressive Disease with Anti-Pd-(l)1 Therapy in Patients with Advanced Merkel Cell Carcinoma

Jeremy Mo,Anne Zaremba,Andrisha-Jade Inderjeeth, Perla El Zeinaty, Ao Li,Alexandre Wicky, Nicholas Della Marta,Caroline Gaudy Marqueste,Ann-Sophie Bohne,Margarida Matias,Nicholas McNamee,Lucia Festino, Charley Chen,Sydney Ch'ng,Alexander C. J. van Akkooi,Laetitia Da Meda,John J. Park,Paolo A. Ascierto,Axel Hauschild,Jenny H. Lee,Jean Jacques Grob,Joanna Mangana,Alex Guminski,Olivier Michielin, Wen Xu,Celeste Lebbe,Shahneen Sandhu,Lisa Zimmer, Alexander M. Menzies,Serigne N. Lo,Georgina V. Long,Matteo S. Carlino,Ines Pires da Silva

EUROPEAN JOURNAL OF CANCER (2025)

引用0浏览0WOS引用

Evolving and Improving the Sustainability of Molecular Tumor Boards: the Value and Challenges

Marius Bartels,Benoist Chibaudel,Rodrigo Dienstmann,Janne Lehtioe,Alberta Piccolo,Olivier Michielin,Grainne O'Kane,Giancarlo Pruneri

Cancersno. 16 (2024): 2888-2888

引用1浏览0WOS引用

Preclinical Model for Evaluating Human TCRs Against Chimeric Syngeneic Tumors

Aikaterini Semilietof,Evangelos Stefanidis,Elise Gray-Gaillard, Julien Pujol, Alessia D'Esposito,Patrick Reichenbach,Philippe Guillaume,Vincent Zoete,Melita Irving,Olivier Michielin

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 12 (2024)

引用0浏览0WOS引用

397 Combination of NY-ESO-1 TCR-T Cells Secreting SiRP-alpha Decoys with Avelumab and Cetuximab Augments Tumor Cell Phagocytosis by Macrophages

Evangelos Stefanidis,Aikaterini Semilietof, Julien Pujol,Bili Seijo,Kirsten Scholten,Vincent Zoete,Olivier Michielin,Raphael Sandaltzopoulos,George Coukos,Melita Irving

Regular and Young Investigator Award Abstracts (2024)

引用0浏览0引用

HoverFast: an Accurate, High-Throughput, Clinically Deployable Nuclear Segmentation Tool for Brightfield Digital Pathology Images

Petros Liakopoulos, Julien Massonnet, Jonatan Bonjour, Medya Tekes Mizrakli, Simon Graham,Michel A. Cuendet, Amanda H. Seipel,Olivier Michielin,Doron Merkler,Andrew Janowczyk

J Open Source Softwno. 101 (2024)

引用0浏览0EI引用

Response to Tumor-Infiltrating Lymphocyte Adoptive Therapy is Associated with Preexisting CD8+ T-myeloid Cell Networks in Melanoma